2 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow NewVac LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy Quisinostat, Paclitaxel, Carboplatin - Ovarian Cancer | Phase 2 | Completed | NewVac LLC | 31 | 2015-09-01 | 2018-06-27 |
| Safety, Tolerability and Pharmacokinetics of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy Quisinostat, Paclitaxel, Carboplatin - Non-small Cell Lung Cancer, Epithelial Ovarian Cancer | Phase 1 | Completed | NewVac LLC | 51 | 2013-08-01 | 2016-05-03 |
Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Ovarian Epithelial (1) · Ovarian Neoplasms (1)
Carboplatin (2) · Paclitaxel (2) · quisinostat (2) · Cisplatin (1) · Gemcitabine (1)
Russia (2)